CASP3 and cancer: This result is in line with early reports which show that the effect of rapamycin on cancer cell viability is strongly dependent on cell type, and high doses are required for apoptosis induction [43,44]; accordingly, 200 μM rapamycin displayed a clear caspase-3 cleavage in M14 and Hela cells (Figure 3D).